CTI BIOPHARMA CORP

CUSIP: 12648L601 Class: Common Stock

DRIEHAUS CAPITAL MANAGEMENT LLC's Holding History (CIK: 0000938206)

Note: Option positions (PUT/CALL) are excluded.

Q3 2022
Shares 1,633,541 Value ($000) $9,507 Avg Close — Range —
Q2 2018
Shares 604,596 Value ($000) $3,011 Avg Close — Range —
Q1 2018
Shares 580,246 Value ($000) $2,263 Avg Close — Range —